Found: 3
Select item for more details and to access through your institution.
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study.
- Published in:
- Experimental Dermatology, 2021, v. 30, n. 11, p. 1686, doi. 10.1111/exd.14253
- By:
- Publication type:
- Article
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany.
- Published in:
- BMC Rheumatology, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41927-024-00387-6
- By:
- Publication type:
- Article
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.
- Published in:
- Rheumatology & Therapy, 2016, v. 3, n. 2, p. 271, doi. 10.1007/s40744-016-0047-x
- By:
- Publication type:
- Article